416 related articles for article (PubMed ID: 32979360)
1. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
Sadeghi S; Soudi S; Shafiee A; Hashemi SM
Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
3. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
Jamshidi E; Babajani A; Soltani P; Niknejad H
Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
[TBL] [Abstract][Full Text] [Related]
4. The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19.
Saburi E; Abazari MF; Hassannia H; Mansour RN; Eshaghi-Gorji R; Gheibi M; Rahmati M; Enderami SE
Gene; 2021 Apr; 777():145471. PubMed ID: 33549712
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
Yadav P; Vats R; Bano A; Bhardwaj R
Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
Front Immunol; 2021; 12():726909. PubMed ID: 34394132
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.
Loke XY; Imran SAM; Tye GJ; Wan Kamarul Zaman WS; Nordin F
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830303
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
12. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19.
Paris GC; Azevedo AA; Ferreira AL; Azevedo YMA; Rainho MA; Oliveira GP; Silva KR; Cortez EAC; Stumbo AC; Carvalho SN; de Carvalho L; Thole AA
Life Sci; 2021 Aug; 278():119510. PubMed ID: 33865879
[TBL] [Abstract][Full Text] [Related]
13. Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
Jeyaraman M; John A; Koshy S; Ranjan R; Anudeep TC; Jain R; Swati K; Jha NK; Sharma A; Kesari KK; Prakash A; Nand P; Jha SK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166014. PubMed ID: 33232817
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for severe COVID-19.
Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
16. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
Cai Q; Yin F; Hao L; Jiang W
Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
Xiong J; Bao L; Qi H; Feng Z; Shi Y
Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
Front Immunol; 2021; 12():738697. PubMed ID: 34659231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
